BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25055034)

  • 41. Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity.
    Erkes DA; Selvan SR
    J Immunol Res; 2014; 2014():175265. PubMed ID: 24949488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity.
    Perret R; Sierro SR; Botelho NK; Corgnac S; Donda A; Romero P
    Cancer Res; 2013 Nov; 73(22):6597-608. PubMed ID: 24048821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased production of antigen-specific B lymphocytes during in vitro immunization using carrier-specific T helper hybridomas.
    Schilizzi BM; Kroesen BJ; The TH; de Leij L
    J Immunol Methods; 1992 Aug; 153(1-2):49-56. PubMed ID: 1387673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody Light Chains Dictate the Specificity of Contact Hypersensitivity Effector Cell Suppression Mediated by Exosomes.
    Nazimek K; Askenase PW; Bryniarski K
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T helper target cell DNA fragmentation through a CD4-positive T suppressor cell clone inducing specific unresponsiveness.
    Becker C; Konur A; Rademaekers A; Kodelja V; Partenheimer A; Pauels HG; Kölsch E
    Cell Immunol; 1994 Feb; 153(2):505-15. PubMed ID: 7907005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of the aryl hydrocarbon receptor reduces the number of precursor and effector T cells, but preserves thymic CD4+CD25+Foxp3+ regulatory T cells.
    Schulz VJ; Smit JJ; Bol-Schoenmakers M; van Duursen MB; van den Berg M; Pieters RH
    Toxicol Lett; 2012 Nov; 215(2):100-9. PubMed ID: 23041608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intestinal dendritic cell licensing through Toll-like receptor 4 is required for oral tolerance in allergic contact dermatitis.
    Hacini-Rachinel F; Gomez de Agüero M; Kanjarawi R; Moro-Sibilot L; Le Luduec JB; Macari C; Boschetti G; Bardel E; Langella P; Dubois B; Kaiserlian D
    J Allergy Clin Immunol; 2018 Jan; 141(1):163-170. PubMed ID: 28342908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contact Hypersensitivity.
    Gaspari AA; Katz SI; Martin SF
    Curr Protoc Immunol; 2016 Apr; 113():4.2.1-4.2.7. PubMed ID: 27038464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B cells are not required for T cell priming in low zone tolerance to contact allergens and contact hypersensitivity.
    Seidel-Guyenot W; Alt R; Perschon S; Knop J; Steinbrink K
    Eur J Immunol; 2004 Nov; 34(11):3082-90. PubMed ID: 15376190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue.
    Ring S; Schäfer SC; Mahnke K; Lehr HA; Enk AH
    Eur J Immunol; 2006 Nov; 36(11):2981-92. PubMed ID: 17048272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance.
    Dubois B; Joubert G; Gomez de Agüero M; Gouanvic M; Goubier A; Kaiserlian D
    Gastroenterology; 2009 Sep; 137(3):1019-28. PubMed ID: 19345221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism.
    Ring S; Oliver SJ; Cronstein BN; Enk AH; Mahnke K
    J Allergy Clin Immunol; 2009 Jun; 123(6):1287-96.e2. PubMed ID: 19427686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epicutaneous immunization with protein antigen in the presence of TLR4 ligand induces TCR alpha beta+CD4+ T contrasuppressor cells that reverse skin-induced suppression of Th1-mediated contact sensitivity.
    Ptak W; Majewska M; Bryniarski K; Ptak M; Lobo FM; Zajac K; Askenase PW; Szczepanik M
    J Immunol; 2009 Jan; 182(2):837-50. PubMed ID: 19124727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allergic contact dermatitis: the cellular effectors.
    Kimber I; Dearman RJ
    Contact Dermatitis; 2002 Jan; 46(1):1-5. PubMed ID: 11918579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epicutaneous administration of hapten through patch application augments TH2 responses which can downregulate the elicitation of murine contact hypersensitivity.
    Wang LF; Sun CC; Wu JT; Lin RH
    Clin Exp Allergy; 1999 Feb; 29(2):271-9. PubMed ID: 10051733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunoregulation of allergic contact dermatitis.
    Girolomoni G; Gisondi P; Ottaviani C; Cavani A
    J Dermatol; 2004 Apr; 31(4):264-70. PubMed ID: 15187320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses.
    Carbone T; Nasorri F; Pennino D; Eyerich K; Foerster S; Cifaldi L; Traidl-Hoffman C; Behrendt H; Cavani A
    J Immunol; 2010 Jan; 184(2):1102-10. PubMed ID: 20008290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of CD4(+) T helper 2-type cells in cutaneous inflammatory responses induced by fluorescein isothiocyanate.
    Dearman RJ; Kimber I
    Immunology; 2000 Dec; 101(4):442-51. PubMed ID: 11122447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.